Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madison Covered Call & Equity Income Fund Class R6 (MENRX)

9.46
Net Asset Value
+0.32%
1 Day
+4.65%
Year-to-Date
Overall Morningstar Rating
Option writing
Style or Category
No Load
Sales Expenses
0.90%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide consistent total return and, secondarily, to provide a high level of income and gains from option premiums. The fund invests, under normal conditions, primarily in common stocks of large- and mid-capitalization issuers that are, in the view of the fund's investment adviser, selling at a reasonable price in relation to their long-term earnings growth rates. It will invest at least 80% of its net assets in common stocks, with at least 65% of this amount invested in common stocks of large capitalization issuers that meet the fund's selection criteria.

Performance

1 month+0.96% 3 years+6.81%
3 months+3.84% 5 years--
1 year+13.95% Since inception+7.80%
Data through --

Peer Comparisonvs. Option writing

 MENRXCategory
Performance 5-yr return--+4.56%
Expense ratio0.90%1.47%
Risk 5 year sharpe ratio0.810.73
Net assets$101.0M$308.6M
Average market cap$48.7B$91.9B
Average P/E20.619.3
Portfolio turnover107%107%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMadison Funds
Fund manager & tenureRay DiBernardo / 6 Years
Minimal initial investment$500,000.00
Minimum IRA investment--

Holdings

U.S. stock75.48%
Cash20.69%
Fixed income2.07%
International stock1.75%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 3.44%
TMUS T-Mobile US Inc3.33%
MSFT Microsoft3.12%
AAPL Apple2.96%
UTX United Technologies2.90%
V Visa2.64%
CBS CBS2.56%
CERN Cerner Corp2.46%
STT State Street2.37%
AGN Allergan2.36%

Partner Offers